Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

被引：16
|
作者：
Anagnostou, Valsamo
Smith, Kellie N.
Forde, Patrick M.
Niknafs, Noushin
Bhattacharya, Rohit
White, James
Adleff, Vilmos
Phallen, Jillian
Wali, Neha
Hruban, Carolyn
Guthrie, Violeta B.
Rodgers, Kristen
Naidoo, Jarushka
Kang, Hyunseok
Sharfman, William
Georgiades, Christos
Verde, Franco
Illei, Peter
Li, Qing Ka
Gabrielson, Edward
Brock, Malcolm
Zahnow, Cynthia
Baylin, Stephen B.
Scharpf, Rob
Brahmer, Julie R.
Karchin, Rachel
Pardoll, Drew M.
Velculescu, Victor E.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-NG01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NG01
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [32] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [33] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [34] Reflections on immune checkpoint inhibition in non-small cell lung cancer
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 411 - 413
  • [35] A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer
    Mason, Mike
    Lapuente-Santana, Oscar
    Halkola, Anni S.
    Wang, Wenyu
    Mall, Raghvendra
    Xiao, Xu
    Kaufman, Jacob
    Fu, Jingxin
    Pfeil, Jacob
    Banerjee, Jineta
    Chung, Verena
    Chang, Han
    Chasalow, Scott D.
    Lin, Hung Ying
    Chai, Rongrong
    Yu, Thomas
    Finotello, Francesca
    Mirtti, Tuomas
    Mayranpaa, Mikko I.
    Bao, Jie
    Verschuren, Emmy W.
    Ahmed, Eiman I.
    Ceccarelli, Michele
    Miller, Lance D.
    Monaco, Gianni
    Hendrickx, Wouter R. L.
    Sherif, Shimaa
    Yang, Lin
    Tang, Ming
    Gu, Shengqing Stan
    Zhang, Wubing
    Zhang, Yi
    Zeng, Zexian
    Das Sahu, Avinash
    Liu, Yang
    Yang, Wenxian
    Bedognetti, Davide
    Tang, Jing
    Eduati, Federica
    Laajala, Teemu D.
    Geese, William J.
    Guinney, Justin
    Szustakowski, Joseph D.
    Vincent, Benjamin G.
    Carbone, David P.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [36] Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
    Harel, Michal
    Lahav, Coren
    Jacob, Eyal
    Dahan, Nili
    Sela, Itamar
    Elon, Yehonatan
    Shoval, Shani Raveh
    Yahalom, Galit
    Kamer, Iris
    Zer, Alona
    Sharon, Ofer
    Carbone, David P.
    Dicker, Adam P.
    Bar, Jair
    Shaked, Yuval
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [37] Driver Mutations are Associated with Distinct Patterns of Response to Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Negrao, M.
    Reuben, A.
    Robichaux, J.
    Le, X.
    Nilsson, M.
    Elamin, Y.
    Wu, C.
    Zhang, J.
    Landry, L. L.
    Roarty, E.
    Rinsurongkawong, W.
    Swisher, S.
    Simon, G.
    Futreal, P. A.
    Glisson, B.
    Zhang, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S733 - S734
  • [38] ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer
    Jiexia Zhang
    Ningning Zhou
    Anqi Lin
    Peng Luo
    Xin Chen
    Huojin Deng
    Shijun Kang
    Linlang Guo
    Weiliang Zhu
    Jian Zhang
    Cancer Immunology, Immunotherapy, 2021, 70 : 137 - 151
  • [39] Overall Survival in Elderly Metastatic Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
    Simoes, M. F.
    Medeiros, M. F.
    Maciel Santana, D.
    De Andrade Souza, C. I.
    Mendes Gomes, L. B.
    De Freitas, H.
    Petrocchi Corassa, M.
    Spina Donadio, M. D.
    De Lima, V. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S290 - S290
  • [40] PREDICTIVE SOLUBLE BIOMARKERS OF IMMUNE RESPONSE TO CHECKPOINT BLOCKADE IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Raza, Afsheen
    Mohsen, Reyad
    Kanbour, Aladdin
    Gul, Abdul Rehman Zar
    Philip, Anite
    Vijayakumar, Suma
    Hydrose, Shereena
    Merhi, Maysaloun
    Inchakalody, Varghese
    Uddin, Shahab
    Al Homsi, Mohammed Ussama
    Dermime, Said
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A19 - A19
12345